paroxetine has been researched along with nadp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapple, S; Collins, C; Fairman, DA | 1 |
Dalvie, DK; Frederick, KS; Kalgutkar, AS; Kelly, JM; Obach, RS; Smith, EB; Soglia, JR; Zhao, SX | 1 |
2 other study(ies) available for paroxetine and nadp
Article | Year |
---|---|
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes | 2007 |
NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Topics: Biotransformation; Cytochrome P-450 CYP2D6 Inhibitors; Glutathione; Humans; Microsomes, Liver; NADP; Paroxetine; Quinones; Tritium | 2007 |